BetterLife Pharma Inc. filed its 20-F on May 31, 2023 for the period ending Jan 31, 2023. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0753 USD | -1.62% | +1.07% | +56.88% |
Apr. 03 | BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding | CI |
Mar. 04 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+56.88% | 8.74M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.04% | 22.18B | |
-16.67% | 21.2B | |
-8.52% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- BETRF Stock
- News BetterLife Pharma Inc.
- BetterLife Pharma Inc. Auditor Raises 'Going Concern' Doubt